nuciferine has been researched along with Obesity in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 7 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ao, H; Chen, L; Peng, C; Tang, F; Wan, Y; Wu, JJ; Xia, J; Xu, JF; Yang, Y | 1 |
| Duan, L; Gong, F; Guo, X; Lyu, X; Pan, H; Wang, L; Xu, H; Yang, H; Zhu, H | 1 |
| Hao, R; Si, F; Zhang, C; Zheng, J; Zhu, X | 1 |
| Chang, XY; Chen, X; Hu, MG; Lu, J; Lyu, X; Mi, X; Sun, L; Wu, C; Yu, Y | 1 |
| Gong, S; Li, B; Liu, M; Qian, S; Wang, J; Wang, Y; Wei, B; Wei, M; Yao, W | 1 |
| Cui, HT; Liao, JB; Wang, HW; Wen, WB; Xiong, WT; Yang, ZX; Zhang, ZY | 1 |
| Du, XL; Fang, ZY; Gao, XX; Li, XW; Liu, GW; Ouyang, HL; Shi, Z; Song, YX; Wang, Z; Yu, H; Zhu, YW | 1 |
1 review(s) available for nuciferine and Obesity
| Article | Year |
|---|---|
Nuciferine, an active ingredient derived from lotus leaf, lights up the way for the potential treatment of obesity and obesity-related diseases.
Topics: Animals; Anti-Obesity Agents; Aporphines; Humans; Lotus; Obesity; Plant Leaves | 2022 |
6 other study(ies) available for nuciferine and Obesity
| Article | Year |
|---|---|
Distinct AMPK-Mediated FAS/HSL Pathway Is Implicated in the Alleviating Effect of Nuciferine on Obesity and Hepatic Steatosis in HFD-Fed Mice.
Topics: AMP-Activated Protein Kinases; Animals; Aporphines; Diet, High-Fat; Fatty Liver; Lipids; Liver; Male; Mice; Mice, Inbred C57BL; Obesity | 2022 |
Nuciferine Protects against Obesity-Induced Nephrotoxicity through Its Hypolipidemic, Anti-Inflammatory, and Antioxidant Effects.
Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Antioxidants; Diet, High-Fat; Inflammation; Mice; NF-kappa B; Obesity; Oxidative Stress; Palmitic Acid | 2023 |
Akkermansia muciniphila: A potential novel mechanism of nuciferine to improve hyperlipidemia.
Topics: Akkermansia; Animals; Anti-Bacterial Agents; Aporphines; Bacteroides; Biomarkers; Diet, High-Fat; Disease Models, Animal; Gastrointestinal Microbiome; Hyperlipidemias; Hypolipidemic Agents; Intestines; Lipids; Male; Metagenome; Metagenomics; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; RNA-Seq | 2021 |
Nuciferine modulates the gut microbiota and prevents obesity in high-fat diet-fed rats.
Topics: Animals; Aporphines; Diet, High-Fat; Dose-Response Relationship, Drug; Dysbiosis; Fatty Acids; Gastrointestinal Microbiome; Lipid Metabolism; Metabolome; Metabolomics; Metagenome; Metagenomics; Obesity; Protective Agents; Rats | 2020 |
[Effect of nuciferine on gut microbiota and inflammatory response in obese model mice].
Topics: Animals; Aporphines; Diet, High-Fat; Gastrointestinal Microbiome; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity | 2021 |
Nuciferine improves high-fat diet-induced obesity
Topics: Animals; Aporphines; Autophagy; Caco-2 Cells; Diet, High-Fat; Dietary Supplements; Epithelium; Gastrointestinal Microbiome; HT29 Cells; Humans; Intestines; Male; Mice; Mice, Inbred C57BL; Obesity; Permeability; Weight Gain | 2021 |